ClinicalTrials.gg
RecruitingNCT06679621TIPPS-UrogynUpdated Aug 14, 2026

A Telehealth Intervention to Increase Patient Preparedness for Surgery in Latinas

An interventional study of Telehealth intervention in Incontinence and Prolapse, sponsored by University of Alabama at Birmingham. Recruiting at 1 site in United States. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-14.

Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Nov 2024; still recruiting 2 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
357
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

There are 3 aims of this study. In Aim 1 community patient partners will be enrolled to help guide the research being performed in all of the aims. Investigators will also administer a survey that will help determine factors associated with surgical preparedness. In Aim 2 investigators will develop an intervention to increase surgical preparedness using Human Centered Design Methods. Aim 3 will pilot test the intervention using mixed methods to determine feasibility and implementation outcomes.

Read the detailed description

The purpose of this project is to understand surgical preparedness in Latinas undergoing urogynecologic surgery and to develop TIPPS-Latina a refined version of our telehealth intervention for Latinas undergoing urogynecologic surgery using HCD and D\&I methods. The goal of the first aim is to develop a participatory design approach and understand surgical preparedness in Latinas undergoing urogynecologic surgery. This cross-sectional study will run in parallel to the other aims. The participatory action framework will guide Aims 1-3. The goals of Aim 2 and Aim 3 are develop and test TIPPS-Latina using the Discover, Design/Build, and Test (DDBT) framework, which is a HCD method to generate evidence-based interventions and their implementations9. During the Discover phase investigators will identify preferences for refinement of TIPPS-Latina and its contextual deployment using mixed methods. During the Design/Build phase investigators will use an iterative process to generate, modify, and adapt our intervention. During the Test phase investigators will conduct pilot testing of TIPPS-Latina using a mixed methods approach that determines feasibility and implementation outcomes. Throughout our study, surgical preparedness will be measured using the Surgical Preparedness Assessment (SPA), a validated survey for measuring preparedness in women undergoing urogynecologic surgery that was developed by our group

02

Conditions studied

  • Incontinence
  • Prolapse

Browse trials for

03

In context

Prolapse

93 studies on the registry are indexed under Prolapse; 9 are open to participants now.

This study's planned enrollment of 357 is above the median of 70 across 65 interventional studies indexed under Prolapse.

Browse Prolapse studies →

Lead sponsor

University of Alabama at Birmingham is the lead sponsor of 1,421 studies on the registry; 277 are open to participants now.

Of its 164 completed or terminated interventional studies of FDA-regulated products, 130 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Patients who

  • Self-report as female
  • 18 years and older
  • Self-report as Hispanic ethnicity
  • Scheduled to undergo a surgery for a urogynecologic condition in the operating room (surgery to correct pelvic organ prolapse, urinary/fecal incontinence, fistula, urethral masses)
  • Able to read and write English and/or Spanish

Urogynecologists who -Routinely perform urogynecologist surgeries to correct pelvic organ prolapse, urinary/fecal incontinence, fistula, urethral masses

Nurses who

  • Spend most of their time at a urogynecologic clinic
  • Engage in the process of preparing patients for urogynecologic surgery

Exclusion criteria

Exclusion Criteria:

Patients who

  • Self-report as male
  • Are less than 18 years of age
  • Self-report as not of Hispanic ethnicity
  • Scheduled to undergo a surgery for a condition that is not urogynecologic or is not in the operating room
  • Patients undergoing procedures that are traditionally performed in the office (bladder Botox, pelvic floor Botox, urethral bulking)

Urogynecologists who

-Do not routinely perform urogynecologic surgery

Nurses who

  • Do not spend most of their time at a urogynecology clinic
  • Do not engage in the process of preparing patients for urogynecologic surgery
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
357 participants (estimated)

Study arms

  • No intervention
    Routine Preoperative Counseling

    Participants scheduled to undergo urogynecologic surgery will receive routine preoperative counseling.

  • Experimental
    Telehealth intervention

    Patient scheduled to undergo urogynecologic surgery will receive routine preoperative counseling in addition to the modified telehealth intervention.

    Behavioral: Telehealth intervention

Interventions

  • BehavioralTelehealth intervention

    This telehealth intervention will be made using human centered design methods

06

What researchers measure

Primary outcomes

  1. Feasibility of the Intervention

    A feasible study will be defined a 1) \>4 on 1-5 Likert-type scales of acceptability, appropriateness, and feasibility; 2) \>70% for adherence; and 3)\> 90% for dose delivery, and percent completed intervention. Acceptability will be measured by the Acceptability of the Intervention Measure Appropriateness will be measured by the Intervention Appropriateness Measure Feasibility will be measured by the Feasibility of Intervention Measure

    Time frame: Day of Surgery, before surgery, in the preoperative holding

  2. Acceptability of the Intervention

    As measured by the Acceptability of the Intervention Measure

    Time frame: Day of Surgery, before surgery, in the preoperative holding

  3. Appropriateness of the Intervention

    As measured by the Intervention Appropriateness Measure

    Time frame: Day of Surgery, before surgery, in the preoperative holding

Secondary outcomes

  1. Surgical Preparedness

    As measured by the Surgical Preparedness Assessment survey

    Time frame: Day of Surgery, before surgery, in the preoperative holding

  2. Health Literacy

    As measured by the Brief Health Literacy Screen

    Time frame: Preoperative Visit, before surgery

  3. Self-Efficacy

    As measured by the General Self-Efficacy Scale

    Time frame: Preoperative Visit, before surgery

  4. Trust in Provider

    As measured by the Trust in Provider Scale

    Time frame: Preoperative Visit, before surgery

  5. Decisional Conflict

    As measured by the Decisional Conflict Scale

    Time frame: Day of Surgery, before surgery, in the preoperative holding

  6. Postoperative Anxiety/Depression

    As measured by the Hospital Anxiety/Depression Scale

    Time frame: Preoperative Visit, before surgery

  7. Satisfaction with Healthcare Services

    As measured by the CAHPS Clinician \& Group Visit Adult Survey

    Time frame: Postoperative Visit 6-8 weeks after surgery

Other outcomes

  1. Demographics

    Baseline Case Report Form

    Time frame: Preoperative Visit 6-8 weeks after surgery

  2. Surgical Data

    Surgical Case Report Form

    Time frame: Day of Surgery, before surgery, in the preoperative holding

  3. Adverse Events

    Adverse Events Case Report Form

    Time frame: Postoperative Visit 6-8 weeks after surgery

  4. Symptom Bother - PFDI 20

    As measured by the Pelvic Floor Distress Inventory-20

    Time frame: Preoperative Visit, before surgery and Postoperative Visit 6-8 weeks after surgery

  5. Symptom Bother - PGI-S

    As measured by the Global Impressions of Severity

    Time frame: Preoperative Visit, before surgery and Postoperative Visit 6-8 weeks after surgery

  6. General Health

    EQ-5D-5L

    Time frame: Preoperative Visit, before surgery and Postoperative Visit 6-8 after surgery

  7. Self-Esteem

    Rosenberg Self-Esteem Scale

    Time frame: Preoperative Visit, before surgery

07

Study locations

1 of 1 sites recruiting
  • University of Alabama Birmginham
    Birmingham, Alabama 35294, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06679621
Responsible party
Gabriela Halder (Assistant Professor, University of Alabama at Birmingham) — Principal investigator
First posted
Nov 7, 2024
Start date
Nov 1, 2024
Primary completion
Jun 1, 2027 (estimated)
Completion
Jun 1, 2027 (estimated)
Last update
Aug 14, 2026

Study contacts

Gabriela Halder, MD, MPH
Contact
gehalder@uabmc.edu
205-934-5498
Gabriela Halder, MD, MPH
principal investigator · Assistant Professor

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion